ACHIA

2003 Presentations


Wednesday, February 19, 2003



"Reporting of Serious Adverse Events"
Speaker: Wendy Fanaroff-Ravick
 

"Bio-Defense and Emerging Infections"
Speaker:  David Franz D.V.M., Ph.D.


Thursday, February 20, 2003



"Overview-Directions for the CASG"
Speaker: Richard J. Whitley, M.D.



"Global Clinical Trial Issues: Regulatory/Ethics Mini Symposium Ethics in Clinical Trials"
Speaker: David Wendler



"Immunocompromised Host"
Speaker: Paul Griffiths, M.D.



"HSV Infections of the CNS in Adults"
Speaker: Kenneth Tyler, M.D.



"Enterovirus (#106) Trial"
Speakers: Mark Abzug, M.D. & David Kimberlin, M.D.



"BK Virus (#209)"
Speaker: Ajit Limaye, M.D.
 


*To get information on West Nile, visit the CDC website www.cdc.gov

Friday, February 21, 2003



"Neonatal Herpesviruses: New Analyses"
Speaker: Richard J. Whitley, M.D.



"HSV CNS (103) and HSV SEM (104)"
Speaker: David Kimberlin, M.D.



"CMV Follow-up (108) and Valgan (109)"
Speaker: David Kimberlin, M.D.



"HSE (204)"
Speaker: John Gnann, M.D.

 

Breakout Sessions


"Adult Transplantation Subcommittee"
Speaker: Paul Griffiths, M.D.



"Pediatric Enterovirus"
Speaker: Mark Abzug, M.D.



"Pediatric Herpesviruses"
Speaker: David Kimberlin, M.D.
 

"West Nile Virus"
Speaker: Amy Agrawal, M.D.